A consortium led by UFG Private Equity, the buyout and growth capital arm of Russia-based alternative investment group UFG Asset Management, and banking and financial institution Gazprombank have acquired a 100 percent stake in Russia-based drug manufacturer Segmenta Pharmaceuticals. The investor group, which also includes pharmaceuticals industry veteran Andrei Mladentsev, plans to acquire other drug makers in Russia and drive consolidation in the industry. Financial details of the transaction, which was structured through holding company Alvansa, were not disclosed.